Romslo I, Gadeholt H G, Høvding G
Arch Dermatol. 1982 Sep;118(9):668-71.
A patient with erythropoietic protoporphyria was observed for 28 years. At the age of 38 years, cholestatic jaundice and rapidly deteriorating liver function developed. The patient died of massive bleeding from esophageal varices. During his terminal illness, the RBC protoporphyrin level rose to about 350 times the upper limit of normal, the urine contained increased protoporphyrins and coproporphyrins, but the stool porphyrin level was only moderately increased. Therapy with cholestyramine resin and vitamin E was associated with a decline in the RBC protoporphyrin level and a transient increase in the stool protoporphyrin level. The increase in RBC and serum protoporphyrin levels during the patient's terminal illness was not accompanied by an exacerbation of cutaneous photosensitivity.
对一名红细胞生成性原卟啉病患者进行了28年的观察。38岁时,出现胆汁淤积性黄疸,肝功能迅速恶化。患者死于食管静脉曲张大出血。在其临终期间,红细胞原卟啉水平升至正常上限的约350倍,尿液中原卟啉和粪卟啉含量增加,但粪便卟啉水平仅适度升高。用消胆胺树脂和维生素E治疗使红细胞原卟啉水平下降,粪便原卟啉水平短暂升高。患者临终期间红细胞和血清原卟啉水平升高并未伴有皮肤光敏性加重。